Cointime

Ovagen

company

About

Ovagen is a biotechnology company.

  • 1 - 10

Highlights

Total Funding Amount
€2.50M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biotechnology
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
Ovagen has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Jun 22, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 22, 2022 Grant €2.50M 1 European Innovation Council — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Ovagen is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท